Apex Peptide Index™
KPV (Lys-Pro-Val)
Also referred to as: Lys-Pro-Val
Overview
KPV is a three-amino-acid peptide derived from alpha-melanocyte-stimulating hormone (alpha-MSH). It has been investigated for potential effects on inflammatory responses, microbial activity, and tissue recovery, but the supplied notes do not establish clinical benefit.
Biological background
KPV comprises lysine, proline, and valine and represents a short fragment of the larger alpha-MSH molecule. The guide places it within research on immune regulation and inflammatory processes affecting skin and intestinal tissues.
Mechanism
The source associates KPV with modulation of inflammatory activity, although it does not identify specific signaling pathways or molecular binding partners. It also describes antimicrobial activity and possible involvement in tissue restoration without providing enough experimental detail to evaluate these mechanisms.
Molecular target
Cellular signal
Biological process
Research areas
Evidence
LEVEL 02 · Preclinical research
Laboratory or animal research exists. Findings do not transfer reliably to people.
Evidence levels reflect the state of documented research only. They are not rankings of popularity, quality or suitability, and a higher level never implies that a compound is an approved medicine.
What the source states
The source guide presents KPV as a peptide with potential relevance to inflammation, microbial defense, and repair processes. It emphasizes possible applications involving skin and intestinal inflammation. The guide also portrays tolerability favorably, but the extracted material provides no study references or supporting safety results.
Source: The Complete Guide to Peptides: Unlocking the Secrets to Health, Healing and Longevity — Hack Smith, Chapter 7, Introduction to Bioregulators (page references not verified)
Summarised in our own wording from the cited reference. The reference is a popular guide, not peer-reviewed literature; its statements are reported here as source claims rather than established facts.
Dosage, reconstitution and administration guidance is deliberately excluded from this platform.
What remains uncertain
The notes do not establish the quality, reproducibility, or human relevance of the reported findings. The extent of clinical investigation and the relationship between proposed biological activity and meaningful health outcomes remain unclear.
Safety information
Safety data are limited, and the supplied material does not substantiate broad assurances of tolerability. Possible adverse effects, interactions, and longer-term risks cannot be characterized from these notes. This summary is educational and is not medical advice.
Regulatory context
Research-stage compound unless otherwise established by a competent authority. Regulatory classification differs between jurisdictions and can change over time; nothing here indicates marketing authorisation.
References
Primary reference for this entry:
The Complete Guide to Peptides: Unlocking the Secrets to Health, Healing and Longevity — Hack Smith, Chapter 7, Introduction to Bioregulators (page references not verified)
Suggested literature search terms taken from the source. They are search starting points, not citations to specific studies.
- “KPV peptide inflammation regulation”
- “KPV bioregulator immune response”
- “KPV peptide antimicrobial properties”
Editorial record
- Editorial status
- source reviewed
- Last updated
- 2026-09-14
- Last reviewed
- 2026-09-13
- Language
- EN
- · Bioregulator classification requires clarification
- · Preclinical evidence rating is provisional
- · Claims of extensive research lack supporting references
- · Broad safety assurances are insufficiently supported
- · Unexplained text artifact in safety notes
APEX PHARMA 360® provides scientific and educational information for informational purposes only. The information presented on this platform is not intended to diagnose, treat, cure or prevent any disease and does not constitute medical advice, medical treatment or a recommendation to use any particular substance or compound. Scientific research and regulatory status can change over time and may differ between jurisdictions. Experimental or research-stage compounds should not be interpreted as approved medicines. Always consult an appropriately qualified healthcare professional for individual medical questions and verify applicable laws and regulatory requirements in your jurisdiction.
